PDAC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
PDAC
Jun 27, 2024, 14:31 |
Societies
Keep up with ESMOGI24 with Teresa Macarulla
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 26, 2024, 12:40 |
Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 26, 2024, 08:00 |
Insight
New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial
Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…
Jun 24, 2024, 15:49 |
Insight
Tanja Obradovic: The landscape of targeting KRAS mutations just got busier
Tanja Obradovic shared on LinkedIn: . "The landscape of KRAS mutations…
Jun 8, 2024, 09:58 |
Insight
Angelo Pirozzi: Circulating immune-related proteins might predict the efficacy of Immune Checkpoint Inhibitors
Angelo Pirozzi, Research Fellow at Mayo Clinic, shared on X: .…
Jun 2, 2024, 22:12 |
Blog
Jacquelyne Gaddy non-genomic factors are likely the cause of outcome disparities in PDAC - Yale Cancer Center
Yale Cancer Center shared on X/Twitter: "Jacquelyne Gaddy presents research showing non-genomic factors are likely the…
May 28, 2024, 08:56 |
Blog
Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix),…
Apr 19, 2024, 16:30 |
Insight
New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance
Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…
All:
8
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube